Tackling pharma’s regulatory issues in digital marketing

03 Apr 2012

When it comes to pharmacovigilance and social media, there is limited guidance on it. So if a company is pursuing a particular digital activity then it has to follow internal best practices.

This of course means engaging with the right people within the company to find out exactly what best practice means in this context.

Marketers could choose not to worry too much about regulatory intricacies, as long as they engage the right people in their company when they start a project so they have access to the right advice.

But digital marketing expert Kai Gait says that is not the best policy.

“Compliance is always highlighted as an issue and marketers can’t leave it to their approval teams to understand how digital is evolving,” he says.

“Marketers need to improve their own compliance knowledge and work to educate their teams around digital to maximise the opportunities available to them,” he concludes.

Digital Intelligence Blog

UK pharmacists get social media guidance
Royal Pharmaceutical Society collects crowd-sourced tools and information on how to use Twitter, Facebook etc
21st May 2013
NHS to receive £260m for patient safety technology
Majority of hospital fund will be used for electronic prescribing
20th May 2013
UCB and IBM to harness big data for personalised epilepsy care
Joint project could pave the way for therapy area use of IBM's Watson
17th May 2013
Sanofi partners with PatientsLikeMe to promote its clinical trials
Online patient community will match patients to the pharma company's trials
16th May 2013
Brazil eHealth pilot improves healthcare access for city poor
Rio de Janeiro project also finds eHealth integration provides major cost savings for health system
15th May 2013
more